Skip to content
Loading…
The boom in GLP-1 weight-loss drugs is boosting demand for protein supplements and driving a rally in the stock of Glanbia Plc, a maker of nutrition products popular with gym enthusiasts and athletes.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.